Evidence map›Paper›PMID 38629842›Full record

ArticleInfection and immunity2024

The prostaglandin D2 antagonist asapiprant ameliorates clinical severity in young hosts infected with invasive

Manmeet Bhalla, Sydney Herring, Alexsandra Lenhard, Joshua R Wheeler, Fred Aswad, Klaus Klumpp, Justin Rebo, Yan Wang, Kevin Wilhelmsen, Kristen Fortney and 1 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Manmeet BhallaDepartment of Microbiology and Immunology, School of Medicine, University at Buffalo, Buffalo, New York, USA.ORCID 0000-0001-9382-6538
Sydney HerringDepartment of Microbiology and Immunology, School of Medicine, University at Buffalo, Buffalo, New York, USA.
Alexsandra LenhardDepartment of Microbiology and Immunology, School of Medicine, University at Buffalo, Buffalo, New York, USA.
Joshua R WheelerDepartment of Pathology, Stanford University, Stanford, California, USA.
Fred AswadBIOAGE Labs Inc., Richmond, California, USA.
Klaus KlumppBIOAGE Labs Inc., Richmond, California, USA.
Justin ReboBIOAGE Labs Inc., Richmond, California, USA.
Yan WangBIOAGE Labs Inc., Richmond, California, USA.
Kevin WilhelmsenBIOAGE Labs Inc., Richmond, California, USA.
Kristen FortneyBIOAGE Labs Inc., Richmond, California, USA.
Elsa N Bou GhanemDepartment of Microbiology and Immunology, School of Medicine, University at Buffalo, Buffalo, New York, USA.ORCID 0000-0002-8936-1341
University at Buffalo, State University of New York · USStanford University · US

Funding

The role of neutrophils in the age-driven decline in anti-pneumococcal vaccine responsesR01AG068568 · NIA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BOU GHANEM, ELSA · 2021 to 2025
$2.0M
NIA NIH HHS R01 AG068568
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pneumococcal InfectionsAnimalsDisease Models, AnimalFemaleLungMiceMice, Inbred C57BLNeutrophilsReactive Oxygen SpeciesStreptococcus pneumoniaeReactive Oxygen SpeciesasapiprantBGE-175eicosanoidsPMNspneumococcus

Identifiers

PMID38629842
PMCPMC11075459
OpenAlexW4394873924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.